Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Piramal Pharma Ltd

Piramal Pharma Ltd share price and stock overview

Piramal Pharma Ltd (NSE: PPLPHARMA, BSE: 543635) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE0DK501011 and a face value of Rs 10. As of 08 August 2026, it trades at Rs (209.55) with a market capitalisation of Rs 27878.43 crore. Figures are live and subject to change.

Piramal Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln
NSE BSE
209.55 1.31 (0.63%) upARrowC
As on: 08-Aug-2026 , 10:03 PM
Market Cap(₹Cr) 27878.43
Book Value(₹Cr) 61.1809785
BSE Code : 543635 NSE Symbol : PPLPHARMA EPS(TTM) : 5.82 ISIN Demat : INE0DK501011 P/E(TTM) : 35.98 Face Value(₹) : 10 Div & Yield % : 0

Today Market

Stock Performance

Today Market

Today's High

78,757.40

Todday's Low

78,377.07

Open at

78,516.08

Previous Close

78,954.76

Volumes

Avg Price

-455.59

Historical Performance

News

07 Aug 26
Piramal Pharma Ltd spurts 1.04%, up for five straight sessions
Piramal Pharma Ltd rose for a fifth straight session today. The stock is quoting at Rs 210.
05 Aug 26
Piramal Pharma Ltd gains for third straight session
Piramal Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 206.
30 Jul 26
Piramal Pharma reports consolidated net loss of Rs 69.39 crore in the June 2026 quarter
Net Loss of Piramal Pharma reported to Rs 69.39 crore in the quarter ended June 2026 as against net loss of Rs 81.
29 Jul 26
Piramal Pharma Ltd soars 0.83%, gains for fifth straight session
Piramal Pharma Ltd is up for a fifth straight session today. The stock is quoting at Rs 195.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
07-08-26 207.00 212.24 205.51 209.55 4611692 36912 966075444.95 24570.65
06-08-26 206.00 212.43 205.00 208.24 7183683 68660 1500804883.28 24636.00
05-08-26 202.49 208.00 200.36 206.78 9351752 53608 1922541213.56 24624.65
04-08-26 200.34 203.95 197.75 202.50 7037103 56774 1413235364.48 24614.90
03-08-26 196.36 202.95 193.03 199.28 7051612 63794 1407073942.19 24774.30
31-07-26 198.06 200.80 193.19 195.61 6600377 54704 1305412509.84 24383.60
30-07-26 194.99 202.26 192.60 196.72 22171172 197829 4399093014.44 24317.15
29-07-26 194.45 201.00 193.20 195.68 11848125 125565 2332009678.82 24250.20
28-07-26 191.75 194.46 187.90 193.43 7171264 58399 1376595608.92 23985.35
27-07-26 180.75 192.64 180.75 192.05 15154930 107479 2877899584.78 23995.95
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

27878.43

PE Ratio

35.98

PB Ratio

3.42

Dividend Yield

0

ROE

8.98

ROCE

10.77

Book Value (₹)

61.1809785

Face Value (₹)

10

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 91750276 6.89 91750276 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2570932 0.19 2570932 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 369003464 27.72 369003464 5
Others 0 0.00 0 0
Sub Total 463324672 34.80 463324672 17
Total ShareHolding for Promoter & Group 463324672 34.80 463324672 17
plus   Publice Share Holding
plus  Institution
Government(Central / State) 5409 0.00 5409 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 9868 0.00 9868 3
Foreign Bank 1332 0.00 1332 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 166633111 12.52 166633111 169
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 13531568 1.02 13531568 10
Mutual Funds / UTI 175491298 13.18 175491298 25
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 5001359 0.38 5001359 28
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 360673945 27.09 360673945 239
plus  Non Institution
Bodies Corporate 15216097 1.14 15216097 1314
Clearing Members 905098 0.07 905098 76
Directors & their Relatives 271868 0.02 271868 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 17315548 1.30 17315548 2
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 15770416 1.18 15770416 7128
Foreign Non Institution Other 238663700 17.93 238663700 1
Hindu Undivided Families 6271291 0.47 6271291 6187
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 46859494 3.52 46859494 718
Individuals holding nominal share capital up to Rs. 1 lakh 146746431 11.02 146746431 445208
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 30127 0.00 30127 12
Others 3228564 0.24 3228564 1
Sub Total 501019831 37.63 501019831 460837
Total Public Shareholding 861693776 64.72 861693776 461076
Total of Promoter & Public ShareHolding 1325018448 99.52 1325018448 461093
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 6329682 0.48 6329682 3
Total Shares held by Custodians and against which Depository Receipts have been issued 6329682 0.48 6329682 3
Grand Total 1331348130 100.00 1331348130 461096

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Net Sales8,869.089,151.188,171.167,081.556,559.10
OPM (%)0.234.532.96-1.607.62
OP20.08414.64242.08-113.19500.06
Other Income213.30134.81175.39225.11275.80
PBIDT995.981,652.571,368.35900.721,269.41
INTEREST340.80421.59448.49344.18198.25
PBDT655.181,230.98919.86556.541,071.16
PBT-372.20414.64116.50-127.11469.90
EO-196.140.00-62.79-6.96-15.08
PBT after EO-176.06414.64179.29-120.15484.98
TAXES149.88323.51161.4766.31109.02
PAT-325.9491.1317.82-186.46375.96
EPS-2.460.680.14-1.543.19
Raw Material22.5022.4624.1923.7623.89
Power and Fuel2.932.922.962.932.49
Employee Cost27.2425.2124.8426.7824.22
Other Manufacturing Expenses1.331.231.321.611.20
Selling and Administration Expenses12.6311.6012.1712.9613.24
Miscellaneous Expenses2.532.051.872.351.07
Revenue (Growth %) -3.0811.9915.397.973.87
PBIDT (Growth %)-39.7320.7751.92-29.04-23.42
PAT (Growth %) -457.66411.39-109.56-149.60-54.98
PBIDT (Margin %)11.2318.0616.7512.7219.35
PAT (Margin %) -3.681.000.22-2.635.73

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 1327.161324.351322.951193.321185.91994.60
Reserves Total 6813.976128.195389.124068.473937.213105.92
Equity Share Warrants0.000.000.000.000.000.10
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds8141.137452.546712.075261.795123.124100.62
Secured Loans 420.861009.06895.581312.681153.7890.20
Unsecured Loans 365.39234.12281.11336.4710.6984.06
Total Debt786.251243.181176.691649.151164.47174.26
Other Liabilities94.3148.5632.2325.5612.916.59
Total Liabilities9021.698744.287920.996936.506300.504281.47
APPLICATION OF FUNDS :
Gross Block 4575.044248.533766.973564.573225.282260.11
Less : Accumulated Depreciation 1539.181354.251154.81962.70786.30633.30
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 3035.862894.282612.162601.872438.981626.81
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress221.11327.30533.24416.57405.16121.00
Producing Properties0.000.000.000.000.000.00
Investments 3579.603105.311708.161746.991629.531591.52
Current Assets, Loans & Advances
Inventories 1873.391205.351153.04818.61535.51420.88
Sundry Debtors 1405.841666.691331.38909.56989.22839.75
Cash and Bank Balance574.32177.84241.7364.16137.23152.35
Loans and Advances 451.00486.00504.12456.23403.17354.52
Total Current Assets4304.553535.883230.272248.562065.131767.50
Less : Current Liabilities and Provisions
Current Liabilities 2416.161391.571348.42872.54845.871264.21
Provisions 46.0842.8584.8339.2153.3140.57
Total Current Liabilities & Provisions2462.241434.421433.25911.75899.181304.78
Net Current Assets1842.312101.461797.021336.811165.95462.72
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets72.2856.5049.1733.8712.371.13
Deferred Tax Liability341.62269.63245.81228.02183.73171.55
Net Deferred Tax-269.34-213.13-196.64-194.15-171.36-170.42
Other Assets612.15529.061467.051028.41832.24649.84
Total Assets9021.698744.287920.996936.506300.504281.47
Contingent Liabilities95.7297.2759.2557.3242.8128.19

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities 896.40290.12451.38-61.74-615.13
Investing Activities -1,164.62-435.05-635.15-551.96-317.83
Net Cash Flow -19.03-73.41174.52-64.93395.16
Operating Activities 249.1971.52358.29548.771,328.12

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Functional Directors
NP
Nandini Piramal
Chairperson / Executive Director
Exec.
PDD
PETER D DEYOUNG
Executive Director & CEO
Exec.
VV
Vivek Valsaraj
Executive Director & CFO
Exec.
Independent Directors
NL
Nathalie Leitch
Independent Non Exe. Director
Ind.
AJ
Amit Jain
Non-Exec & Non-Independent Dir
Ind.
JMP
Jairaj Manohar Purandare
Independent Non Exe. Director
Ind.
SG
Sridhar Gorthi
Independent Non Exe. Director
Ind.
PS
Peter Stevenson
Independent Non Exe. Director
Ind.
VPR
Vibha Paul Rishi
Independent Non Exe. Director
Ind.
AS
AMIT SONI
Independent Non Exe. Director
Ind.
Other Officials
MS
Maneesh Sharma
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Piramal Pharma Ltd? −

Piramal Pharma Ltd trades on NSE under PPLPHARMA and on BSE under code 543635. The ISIN is INE0DK501011 and the face value is Rs 10.

What is the share price of Piramal Pharma Ltd today? +

As of 08 August 2026, Piramal Pharma Ltd trades at Rs 209.55, a change of 1.31 (0.63%) on the day. Prices are live and subject to change.

What is the market capitalisation of Piramal Pharma Ltd? +

As of 08 August 2026, Piramal Pharma Ltd has a market cap of about Rs 27878.43 crore. This figure is live and moves with the share price.

Is Piramal Pharma Ltd profitable? +

In March 2026, Piramal Pharma Ltd reported a profit after tax of Rs -325.94 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Piramal Pharma Ltd? +

: As of 08 August 2026, the PE (TTM) for Piramal Pharma Ltd is 35.98 and the price-to-book ratio is 3.42. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Piramal Pharma Ltd pay a dividend? +

As of 08 August 2026, the dividend yield for Piramal Pharma Ltd is 0%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Piramal Pharma Ltd? +

As of the latest disclosed pattern, promoters hold 34.80% of Piramal Pharma Ltd. Public shareholding is 64.72%, including mutual funds at 13.18% and foreign institutional investors at 12.52%.

What were the latest annual financials of Piramal Pharma Ltd? +

In March 2026, Piramal Pharma Ltd reported net sales of Rs 8,869.08 crore, revenue growth of -3.08%, and earnings per share of Rs -2.46.
We are hiring! Check out open positions and send your CV to csecrecruit@chola.murugappa.com
View Careers
Pre-Apply for IPOs
Chola Securities App
Install
🌐
Stay on Web